Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 1, 2011, Pages 143-153

  Casillas Ramírez, Araní ^a   Alfany Fernández, Izabel ^a   Massip Salcedo, Marta ^a,b   Juan, M Emília ^c   Planas, Joana M ^c   Serafín, Anna ^c   Pallàs, Mercè ^c,d   Rimola, Antoni ^b,e   Rodés, Juan ^a,b   Peralta, Carmen ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECOMBINANT PROTEIN; RECOMBINANT RETINOL BINDING PROTEIN 4; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; FATTY LIVER; ISCHEMIC PRECONDITIONING; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; REPERFUSION INJURY;

ANIMALS; DOWN-REGULATION; FATTY LIVER; LIVER TRANSPLANTATION; PPAR GAMMA; RATS; RATS, ZUCKER; RETINOL-BINDING PROTEINS, PLASMA; UP-REGULATION;

EID: 79959507752     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.177691     Document Type: Article

References (39)

1. Blaner WS (1989) Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 10:308-316.
2. Carrasco-Chaumel E, Roselló-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A, Gelpí E, Rodés J, and Peralta C (2005) Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 43:997-1006.
3. Casillas-Ramírez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, et al. (2008) Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Crit Care Med 36:1256-1266.
4. Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, and Peralta C (2006) Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79:1881-1894.
5. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, and Park KS (2006) Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29:2457-2461.
6. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, and Jochum W (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238:843-852.
7. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, Pirsch JD, Hafez GR, Lorentzen D, and Belzer FO (1991) The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51:157-163.
8. Gieng SH, Raila J, and Rosales FJ (2005) Accumulation of retinol in the liver after prolonged hyporetinolemia in the vitamin A-sufficient rat. J Lipid Res 46:641-649.
9. Gjøen T, Bjerkelund T, Blomhoff HK, Norum KR, Berg T, and Blomhoff R (1987) Liver takes up retinol-binding protein from plasma. J Biol Chem 262:10926-10930.
10. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552-2563.
11. Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, Suzuki Y, Saito H, Kohgo Y, and Okumura T (2005) Increased expression of PPARγ in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 336:215-222.
12. Janke J, Engeli S, Boschmann M, Adams F, Böhnke J, Luft FC, Sharma AM, and Jordan J (2006) Retinol-binding protein 4 in human obesity. Diabetes 55:2805-2810.
13. Kahn BB, Alquier T, Carling D, and Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25.
14. Kamada N and Calne RY (1979) Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28:47-50.
15. Kola B, Boscaro M, Rutter GA, Grossman AB, and Korbonits M (2006) Expanding role of AMPK in endocrinology. Trends Endocrinol Metab 17:205-215.
16. Lage R, Diéguez C, Vidal-Puig A, and López M (2008) AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14:539-549.
17. Lanne B, Dahllöf B, Lindahl C, Ebefors K, Kanmert I, von Bahr H, Miliotis T, Nyström AC, Arnerup G, Paulsons I, et al. (2006) PPARα and PPARγ regulation of liver and adipose proteins in obese and dyslipidemic rodents. J Proteome Res 5:1850-1859.
18. Lee DC, Lee JW, and Im JA (2007) Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 56:327-331.
19. Lin KD, Chang YH, Wang CL, Yang YH, Hsiao PJ, Li TH, and Shin SJ (2008) Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea. Transl Res 151:309-314.
20. Man K, Zhao Y, Xu A, Lo CM, Lam KS, Ng KT, Ho JW, Sun CK, Lee TK, Li XL, et al. (2006) Fat-derived hormone adiponectin combined with FTY720 significantly improves small-for-size fatty liver graft survival. Am J Transplant 6:467-476.
21. Massip-Salcedo M, Roselló-Catafau J, Prieto J, Avíla MA, and Peralta C (2007) The response of the hepatocyte to ischemia. Liver Int 27:6-16.
22. McClain CJ, Van Thiel DH, Parker S, Badzin LK, and Gilbert H (1979) Alterations in zinc, vitamin A, and retinol-binding protein in chronic alcoholics: a possible mechanism for night blindness and hypogonadism. Alcohol Clin Exp Res 3:135-141.
23. Mody N, Graham TE, Tsuji Y, Yang Q, and Kahn BB (2008) Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab 294:E785-E793.
24. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, and Kalayoglu M (1993) Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55:807-813.
25. Rosales FJ, Ritter SJ, Zolfaghari R, Smith JE, and Ross AC (1996) Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. J Lipid Res 37:962-971.
26. Rosales FJ and Ross AC (1998) Acute inflammation induces hyporetinemia and modifies the plasma and tissue response to vitamin A supplementation in marginally vitamin A-deficient rats. J Nutr 128:960-966.
27. Serafín A, Roselló-Catafau J, Prats N, Gelpí E, Rodés J, and Peralta C (2004) Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39:688-698.
28. Sivarajah A, McDonald MC, and Thiemermann C (2005) The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-γ antagonist. J Pharmacol Exp Ther 313:896-901.
29. Smith FR and Goodman DS (1971) The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest 50:2426-2436.
30. Smith JC Jr., Brown ED, White SC, and Finkelstein JD (1975) Letter: Plasma vitamin A and zinc concentration in patients with alcoholic cirrhosis. Lancet 1:1251-1252.
31. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, and Häring HU (2007) High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30:1173-1178.
32. Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, and Kasuga M (2007) Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Metabolism 56:1418-1424.
33. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, and Blaner WS (1992) Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267:1805-1810.
34. Wagnerberger S, Schäfer C, Bode C, and Parlesak A (2006) Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease. Alcohol 38:37-43.
35. Wu H, Wei L, Bao Y, Lu J, Huang P, Liu Y, Jia W, and Xiang K (2009) Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue. Am J Physiol Endocrinol Metab 296:E628-E634.
36. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, and Kahn BB (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362.
37. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, et al. (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92:2590-2597.
38. Yue TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, et al. (2001) In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 104:2588-2594.
39. Zhao CY, Jiang LL, Li L, Deng ZJ, Liang BL, and Li JM (2004) Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World J Gastroenterol 10:1329-1332.